FDA Approves First Systemic Treatment for Alopecia Areata
U.S. Food & Drug Administration
FDA approves Mounjaro™ (tirzepatide) injection for the treatment of type 2 diabetes
U.S. Food & Drug Administration
Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk
CLEVELAND CLINIC JOURNAL OF MEDICINE